Samuel, Tal Y.
Hasin, Tal
Gotsman, Israel
Weitzman, Tanya
Ben Ivgi, Fanny
Dadon, Ziv
Asher, Elad
Amir, Offer
Glikson, Michael
Alcalai, Ronny
Leibowitz, David
Clinical trials referenced in this document:
Documents that mention this clinical trial
Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
https://doi.org/10.1007/s40268-021-00372-1
Article History
Accepted: 21 October 2021
First Online: 26 November 2021
Declarations
:
: Partial funding for this study was provided by Kaneka Co., Japan. The funding source had no role in the collection of data or preparation of the manuscript.
: Tal Y. Samuel, Tal Hasin, Israel Gotsman, Tanya Weitzman, Fanny Ben Ivgi, Ziv Dadon, Elad Asher, Offer Amir, Michael Glikson, Ronny Alcalai, and David Leibowitz have no conflicts of interest to report.
: This study was approved by the Institutional Review Boards of the two participating centers (reference number 129-16).
: All participants provided written informed consent to participate in this study and for the manuscript to be published.
: All data generated in this study are included in the article. Further enquiries should be directed to the corresponding author.
: Not applicable.
: DL, TH, IG, and TYS were involved in the design of the study, interpretation of the data, and drafting of the manuscript. TYS, TW, and ZD were responsible for the enrollment of patients. FBI performed the echocardiographic examinations. EA and RA were involved in interpretation of the data and manuscript revisions. MG and OA critically reviewed the manuscript prior to submission.